Gujarat 8th worse in child, maternal nutrition

AHMEDABAD: Back in March 2016, the Unicef Rapid Survey on Children covering India had warned Gujarat that around 10.1% children in the state were grossly underweight and 41.6% showed stunted growth.

In August 2017, the National Family Health Survey said that among children under the age of 5 in Gujarat, 38.5% were stunted, 26.4% were wasted, and 39.3% were underweight.

Gujarat 8th worse in child, maternal nutrition Now, the latest Lancet Global Health report on the burden of diseases in Indian states says that Gujarat ranked eighth on the parameter of health problems pertaining to child and maternal nutrition, with 5,013 individuals per lakh population suffering.

Yet, between 2016 and 2018, the women and child development department of the state government slashed its budget allocation from Rs 62.13 crore to Rs 38.51 crore!

The Lancet report points that the prevalence of iron deficiency among women and children in Gujarat is higher than that of Bihar, Rajasthan, UP, and Uttarakhand.

In the case of protein energy malnutrition, the prevalence is 243 cases per lakh population, while in the case of neonatal encephalopathy, which is again related to malnutrition, Gujarat has 661 children suffering in every lakh of newborns.

Gujarat is ahead of states like MP, Chhattisgarh, Rajasthan, and UP when it comes to the prevalence of neonatal encephalopathy.

The Lancet study is a revelation that underscores how malnutrition continues to plague Gujarat, which is scoring double-digit growth.

  • Related Posts

    Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

    Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

    HC denies bail to pharma company owner for manufacturing spurious drugs

    Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Glenmark Pharma launches TEVIMBRA in India

    Glenmark Pharma launches TEVIMBRA in India

    India’s herbal and ayurvedic OTC market set to outpace global growth

    India’s herbal and ayurvedic OTC market set to outpace global growth

    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug